SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.200.0%Dec 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (3789)6/26/1997 5:24:00 PM
From: vulture   of 32384
 
Don't know if this is old news to some, but thought I'd post it anyway.Don't know if it matters much anyway. Poor ligand.

NEW YORK, June 18 (Reuter) - Lehman Brothers said it initated coverage of four stocks in
the biotechnology signal transduction sector.

rated Ligand Pharmaceuticals Inc (LGND) a buy. Cadus Pharmaceutical Corp (KDUS) and
ONYX Pharmaceuticals Inc (ONXX) were rated outperform.
put a venture rating on Ariad Pharmaceuticals Inc (ARIA).
``we believe that understanding the pathways of the signaling process improves the pool
of targets one may wish to direct highly specific, often orally available, and strongly
potent drugs,'' a Lehman report said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext